Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Pulmonary

P116 Differences in Patient Outcomes Between a 6, 7 and 8 Week Pulmonary Rehabilitation Programme

Thorax

Pulmonary

Respiratory Medicine

2014

English

MS18.03 Treatment of SCLC Transformed From EGFR Mutant Adenocarcinoma

Journal of Thoracic Oncology

English

P045 Prognostic Value of MHC-I, PD-L1 and CD8+ TILs Expressions in Patients With Surgically Resected Non-Small Cell Lung Cancer

Journal of Thoracic Oncology

English

P1.14-30 Prognostic Factors for Sarcoma Patients With Lung Metastasis Who Underwent Extended Pulmonary Resection

Journal of Thoracic Oncology

English

P3.01-53 Comparison of the Treatment Efficacy of Osimertinib in Young and Elderly Patients With T790m-Positive NSCLC

Journal of Thoracic Oncology

English

P3.01-52 the Role of Serum Carcinoembryonic Antigen to Predict the Response of Treatment in Non-Small Cell Lung Cancer Patients

Journal of Thoracic Oncology

English

Less Toxic Chemotherapy Improves Uptake of All Lines of Chemotherapy in Advanced Non–Small-Cell Lung Cancer: A 10-Year Retrospective Population-Based Review

Journal of Thoracic Oncology

English

Pulmonary Metastasectomy in Colorectal Cancer: The PulMiCC Trial: Figure 1

English

Safety and Tolerability of the Novel Inhaled Corticosteroid Fluticasone Furoate in Combination With the Β2agonist Vilanterol Administered Once Daily for 52 Weeks in Patients ≥12 Years Old With Asthma: A Randomised Trial

English

P2.01-28 Gender and Systemic Treatment Patterns: Impacts on the Overall Survival of Stage IV NSCLC 2010 – 2014 Diagnoses

Journal of Thoracic Oncology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Pulmonary

P116 Differences in Patient Outcomes Between a 6, 7 and 8 Week Pulmonary Rehabilitation Programme

MS18.03 Treatment of SCLC Transformed From EGFR Mutant Adenocarcinoma

P045 Prognostic Value of MHC-I, PD-L1 and CD8+ TILs Expressions in Patients With Surgically Resected Non-Small Cell Lung Cancer

P1.14-30 Prognostic Factors for Sarcoma Patients With Lung Metastasis Who Underwent Extended Pulmonary Resection

P3.01-53 Comparison of the Treatment Efficacy of Osimertinib in Young and Elderly Patients With T790m-Positive NSCLC

P3.01-52 the Role of Serum Carcinoembryonic Antigen to Predict the Response of Treatment in Non-Small Cell Lung Cancer Patients

Less Toxic Chemotherapy Improves Uptake of All Lines of Chemotherapy in Advanced Non–Small-Cell Lung Cancer: A 10-Year Retrospective Population-Based Review

Pulmonary Metastasectomy in Colorectal Cancer: The PulMiCC Trial: Figure 1

Safety and Tolerability of the Novel Inhaled Corticosteroid Fluticasone Furoate in Combination With the Β2agonist Vilanterol Administered Once Daily for 52 Weeks in Patients ≥12 Years Old With Asthma: A Randomised Trial

P2.01-28 Gender and Systemic Treatment Patterns: Impacts on the Overall Survival of Stage IV NSCLC 2010 – 2014 Diagnoses